Motor features in posterior cortical atrophy and their imaging correlates. by Ryan, Natalie S et al.
Ryan, NS; Shakespeare, TJ; Lehmann, M; Keihaninejad, S; Nicholas,
JM; Leung, KK; Fox, NC; Crutch, SJ (2014) Motor features in pos-
terior cortical atrophy and their imaging correlates. Neurobiology of
aging. ISSN 0197-4580 DOI: 10.1016/j.neurobiolaging.2014.05.028
Downloaded from: http://researchonline.lshtm.ac.uk/1848536/
DOI: 10.1016/j.neurobiolaging.2014.05.028
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
Motor features in posterior cortical atrophy and their imaging
correlatesq
Natalie S. Ryan a,*,1, Timothy J. Shakespeare a,1, Manja Lehmann a, Shiva Keihaninejad a,
Jennifer M. Nicholas a,b, Kelvin K. Leung a, Nick C. Fox a, Sebastian J. Crutch a
aDementia Research Centre, Department of Neurodegenerative Disease, University College London (UCL) Institute of Neurology,
Queen Square, London, UK
bDepartment of Medical Statistics, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine,
Keppel St, London, UK
a r t i c l e i n f o
Article history:
Received 12 January 2014
Received in revised form
6 May 2014
Accepted 31 May 2014
Available online 6 June 2014
Keywords:
Posterior cortical atrophy
Corticobasal syndrome
Alzheimer’s disease
Phenotype
Asymmetric atrophy
a b s t r a c t
Posterior cortical atrophy (PCA) is a neurodegenerative syndrome characterized by impaired higher vi-
sual processing skills; however, motor features more commonly associated with corticobasal syndrome
may also occur. We investigated the frequency and clinical characteristics of motor features in 44 PCA
patients and, with 30 controls, conducted voxel-based morphometry, cortical thickness, and subcortical
volumetric analyses of their magnetic resonance imaging. Prominent limb rigidity was used to deﬁne a
PCA-motor subgroup. A total of 30% (13) had PCA-motor; all demonstrating asymmetrical left upper limb
rigidity. Limb apraxia was more frequent and asymmetrical in PCA-motor, as was myoclonus. Tremor and
alien limb phenomena only occurred in this subgroup. The subgroups did not differ in neuropsycho-
logical test performance or apolipoprotein E4 allele frequency. Greater asymmetry of atrophy occurred in
PCA-motor, particularly involving right frontoparietal and peri-rolandic cortices, putamen, and thalamus.
The 9 patients (including 4 PCA-motor) with pathology or cerebrospinal ﬂuid all showed evidence of
Alzheimer’s disease. Our data suggest that PCA patients with motor features have greater atrophy of
contralateral sensorimotor areas but are still likely to have underlying Alzheimer’s disease.
 2014 The Authors. Published by Elsevier Inc. All rights reserved.
1. Introduction
Posterior cortical atrophy (PCA) is a neurodegenerative syn-
drome characterized by progressive decline in visual processing,
literacy, numeracy, and other functions that depend on parietal,
occipital, and occipitotemporal brain regions (Benson et al., 1988;
Kas et al., 2011). Most individuals with PCA have Alzheimer’s dis-
ease (AD) as the underlying pathology, but PCA may also be caused
by corticobasal degeneration (CBD), dementia with Lewy bodies
(DLB), and Creutzfeldt-Jakob disease (CJD) (Renner et al., 2004;
Tang-Wai et al., 2003a, 2003b). Although a relatively homogenous
syndrome, there remains scope for improving the classiﬁcation of
PCA through consensus criteria and establishing clinicopathological
correlations (Crutch et al., 2012). There is a need for a clearer
description of the relationship and overlap between PCA and other
related syndromes, particularly the corticobasal syndrome (CBS).
Although commonly considered a selective visual syndrome, a
number of patients with PCA develop sensorimotor signs, often
asymmetric, which are more typically seen in CBS (Giorelli et al.,
2014; McMonagle et al., 2006; Seguin et al., 2011; Tang-Wai et al.,
2003a; Whitwell et al., 2010). In the original proposed criteria for
PCA, a normal physical examination is considered supportive of a
diagnosis but not mandatory (Mendez et al., 2002). Another pro-
posed criteria excludes early Parkinsonism but recognizes that it
may subsequently develop and does not state how early on its
presence is acceptable (Tang-Wai et al., 2004). The prevalence of
motor features in PCA is currently unclear, as are other potential
differences between PCA patients with and without such signs.
The core clinical features of CBS are progressive asymmetrical
limb rigidity and apraxia (Boeve et al., 2003). There may be addi-
tional cortical signs such as myoclonus, alien limb phenomenon
and cortical sensory loss and extrapyramidal signs including
tremor, bradykinesia, and dystonia. All these signs contribute to the
patient experiencing clumsiness and loss of function of the affected
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limb. Historically, these clinical features were considered to be
diagnostic of CBD (a 4-repeat tau neurodegenerative disease)
(Dickson et al., 2002; Rebeiz et al., 1968), however, numerous
clinicopathological studies have demonstrated that CBD can cause a
variety of different phenotypes including progressive supranuclear
palsy syndrome, frontotemporal dementia, progressive nonﬂuent/
agrammatic aphasia, an executive-motor syndrome, and PCA
(Armstrong et al., 2013; Josephs et al., 2006; Kertesz et al., 2000; Lee
et al., 2011). Furthermore, it has become apparent that CBD pa-
thology is found at autopsy in less than half of the patients who are
clinically diagnosed during life (Boeve et al., 1999; Josephs et al.,
2006; Lee et al., 2011). Increasingly, AD is recognized as an impor-
tant cause of CBS but other alternative pathologies include pro-
gressive supranuclear palsy, Pick’s disease, frontotemporal lobar
degeneration with TAR DNA binding protein inclusions, DLB, and
CJD (Boeve et al., 1999; Hu et al., 2009; Josephs et al., 2006; Ling
et al., 2010; Shelley et al., 2009). The term “CBS” was therefore
coined to refer purely to the constellation of clinical features, in
recognition that they may be caused by diverse underlying pa-
thologies (Boeve et al., 2003; Kertesz et al., 2000).
CBS terminology has been in circulation for over a decade and
during this time, there has been growing appreciation of the
cognitive dysfunction that may feature in the disorder (Rabinovici
and Miller, 2012). Cognitive function was initially reported to be
relatively well preserved until late in the disease and initial diag-
nostic criteria made early dementia an exclusion criterion (Lang
et al., 1994; Rebeiz et al., 1968). However, increasing numbers of
studies reported cognitive symptoms early in the course of CBS or
even predating the emergence of motor features (Graham et al.,
2003; Grimes et al., 1999; Kertesz et al., 2000; Murray et al.,
2007; Schneider et al., 1997). Although no consensus yet exists for
the diagnosis of CBS, proposed criteria have subsequently included
cognitive dysfunction as a supportive feature (Boeve et al., 2003) or
have given equal weight to the cognitive and motor aspects of the
disorder (Mathew et al., 2012). In addition to limb apraxia, the
characteristic cognitive manifestations of CBS are frontal dysfunc-
tion and language impairment (typically nonﬂuent aphasia), but
also dysgraphia, dyscalculia, and visuospatial deﬁcits (Graham
et al., 2003; Mathew et al., 2012). The relationship between CBS,
frontotemporal lobar degeneration, and primary progressive
aphasia has been the subject of a number of studies (Josephs et al.,
2006; Kertesz et al., 2000), however, the overlap between CBS and
PCA has received comparatively little attention. The aims of this
study were to ascertain how frequently the core features of CBS
were observed in a relatively large cohort of PCA patients and
compare the clinical and neuroimaging proﬁles of PCA patients
with and without these signs. In line with previous evidence of an
association between CBS and perirolandic atrophy irrespective of
underlying pathology (Lee et al., 2011), we hypothesized that PCA
patients with motor features would show greater atrophy of
contralateral sensorimotor cortices.
2. Methods
2.1. Subject characteristics
The study was conducted at the Dementia Research Centre
(DRC), University College London Institute of Neurology, at the
National Hospital for Neurology and Neurosurgery. Most of the
subjects in this study had attended our Specialist Cognitive Dis-
orders Clinic for their clinical assessment. The DRC database was
interrogated to identify individuals with a clinical diagnosis of
PCA and at least 1 magnetic resonance imaging (MRI) brain scan
and a neurologist then reviewed their clinical notes. Subjects
were included if they met the original proposed clinical criteria
for PCA (Mendez et al., 2002), of presentation with progressive
visual complaints, intact primary visual functions, and a pre-
dominant complex visual disorder on examination, with propor-
tionally less impaired memory and insight. They were only
included in this study if they had a clearly documented neuro-
logical examination within a year of their MRI scan. A total of 44
individuals with PCA were identiﬁed, along with 30 healthy
controls. Informed consent was obtained from all subjects ac-
cording to the Declaration of Helsinki and the study had local
ethics committee approval. Some of the patients had been
included in preceding studies from our group (Crutch et al., 2011,
2013a; Lehmann et al., 2011a, 2011b, 2012; Kennedy et al., 2012;
Ridgway et al., 2012; Shakespeare et al., 2013; Witoonpanich
et al., 2013; Yong et al., 2013).
The same neurologist reviewed all the clinical assessment notes
to ascertain the age at symptom onset, mini-mental state exami-
nation (MMSE) (Folstein et al., 1975) score and the presence of limb
rigidity, apraxia, myoclonus, tremor, dystonia, and alien limb phe-
nomenon at the time of scanning. Not all patients were consistently
examined for cortical sensory signs or bradykinesia so these fea-
tures were not considered for the purpose of this study. If the motor
signs were observed on clinical examination to affect one side only
or one side more than the other, this asymmetry was documented.
Limb rigidity is a core feature shared by all 3 of the existing diag-
nostic criteria for CBS (Boeve et al., 2003; Lang et al., 1994; Mathew
et al., 2012) and was used to deﬁne the group membership for this
study. Patients were classiﬁed as PCA-motor if prominent limb ri-
gidity was present or PCA-pure if absent. They were not included in
the PCA-motor group if a very subtle increase in limb tone was only
evident on testing with synkinesis.
Six patients had undergone lumbar puncture (LP). Cerebrospinal
ﬂuid (CSF) was analyzed for 14-3-3 protein positivity and total tau
and amyloid beta (Ab1-42) concentrations (Innotest platforms,
Innogenetics, Ghent, Belgium). According to our laboratory’s local
reference ranges, a CSF proﬁle is considered to show 85% sensitivity
for a clinical diagnosis of AD when tau >307pg/mL and Ab1-42
<325pg/mL (unpublished data). Two patients had come to post-
mortem and a third patient had undergone brain biopsy. DNA was
available for 40 of the PCA patients, whichwas analyzed to establish
apolipoprotein E (APOE) genotype.
2.2. Neuropsychological assessment
Detailed neuropsychological assessment was available for 21/31
(67%) PCA-pure and 9/13 (69%) PCA-motor patients. This included
tests of visuospatial processing (number location and dot counting
from the Visual Object and Space Perception battery; Warrington
and James, 1991), visuoperceptual processing (fragmented letters
and object decision from the Visual Object and Space Perception
battery), calculation (Graded Difﬁculty Arithmetic test; Jackson and
Warrington, 1986), spelling (Baxter Graded Difﬁculty Spelling test;
Baxter and Warrington, 1994), verbal and visual memory (Short
Recognition Memory Test for words and faces (Warrington, 1996)),
naming from verbal description and praxis (gesture production in
the dominant upper limb, a subset of 5 of the traditional gesture
tasks from Crutch et al., 2007).
The limb apraxia subtest of the Apraxia Battery for Adults (ABA-
2,3A) (Dabul, 2000) was recently introduced into our clinical
assessment protocol to provide a standardized assessment of limb
praxis. Therefore, this subtest was available for only the 8 most
recently assessed patients (4 PCA-motor, 4 PCA-pure). In this
assessment, 10 different actions are verbally described and the
subject is scored out of 5 to record how accurately they perform
each gesture. We conducted the assessment separately for the right
and left upper limb to give a total score of 50 for each limb, from
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which the difference between scores for left and right could be
calculated.
2.3. MRI acquisition
T1-weighted volumetric MR brain scans were acquired on a
3.0 T Siemens TIM Trio scanner (N ¼ 43, Siemens, Erlangen, Ger-
many) using a magnetization prepared rapid gradient echo
sequence with a 28.2 cm ﬁeld of view to provide 208 contiguous
1.1 mm thick slices, and on 1.5 T GE Signa units (N ¼ 31, General
Electric, Milwaukee, WI, USA) using a spoiled gradient recalled
sequence with a 24 cm ﬁeld of view to provide 124 contiguous 1.5-
mm thick slices. The proportion of patients scanned on each
scanner was balanced across groups (Table 1). Full details of the
scanner acquisition protocols can be found in the Supplementary
Information.
2.4. Voxel-based morphometry processing
Voxel-based morphometry (VBM) was carried out using SPM8
(Statistical Parametric Mapping, version 8; Wellcome Trust Centre
forNeuroimaging, London,UK). Scanswere segmented intograyand
white matter using SPM8’s new segment toolbox with default set-
tings (Ashburner and Friston, 2005; Weiskopf et al., 2011). Seg-
mentations were produced with rigid alignment to standard space
(Montreal Neurological Institute [MNI] space) and resampled to
1.5 mm isotropic voxels for use with DARTEL (Ashburner, 2007).
DARTEL then iteratively registered the gray and white matter seg-
ments to an evolving estimate of their group-wise average
(Ashburner and Friston, 2009). The native space tissue segments
were then normalized to MNI space using the DARTEL trans-
formations, modulated to account for local volume changes. A 6mm
full width at halfmaximumGaussian smoothing kernelwas applied.
Total intracranial volume (TIV) for each participant was estimated
using Jacobian integration of deformation ﬁelds. An explicit mask
was applied to include only voxels for which the intensity was at
least 0.1 in at least 80% of the images (Ridgway et al., 2009).
2.5. Cortical thickness processing
Cortical thickness measurements were made using FreeSurfer
version 5.1.0 (http://surfer.nmr.mgh.harvard.edu/). The detailed
procedure has been described and validated in previous publica-
tions (Dale et al., 1999; Fischl and Dale, 2000). Twomodiﬁcations to
the standard FreeSurfer processing stream were made: a locally
generated brain mask was used to improve skull stripping, and
FreeSurfer ventricular segmentations were added to the white
matter mask to improve cortical segmentation.
2.6. Whole-brain analysis of VBM and cortical thickness data
A general linear model was used to assess group differences in
gray andwhite matter volume in the VBM analysis (implemented in
SPM) and cortical thickness in the FreeSurfer analysis (imple-
mented using SurfStat, http://www.math.mcgill.ca/keith/surfstat/
(Chung et al., 2010) and a locally-developed Matlab toolkit). Vol-
ume and cortical thickness were modeled as a function of group
(controls, PCA-pure, and PCA-motor), adjusting for age, gender, TIV
(all mean centered) and scanner. Statistical signiﬁcance of differ-
ences between groups was tested using family-wise error (FWE)
correction at p < 0.05. Maps showing statistically signiﬁcant dif-
ferences between the controls and patient groups as well as maps
showing percent differences between the 2 patient groups were
generated.
2.7. Cortical region of interest analysis
Cortical thickness values were extracted for 34 brain areas in the
left and right hemisphere using FreeSurfer’s Desikan parcellation
(Desikan et al., 2006). These areas were grouped into 5 larger
Table 1
Subject characteristics and clinical data
Controls (N ¼ 30) PCA-motor (N ¼ 13) PCA-pure (N ¼ 31) p-value
Gender (male, female) 13, 17 7, 6 12, 19 0.71a
Age in years, mean (SD) 63.9 (6.2) 63.8 (8.0) 63.4 (6.2) 0.94b
MMSE, mean (SD) 29.3 (0.8) 17.4 (6.3) 18.9 (6.4) 0.49c
Disease duration in years, mean (SD) NA 4.9 (2.1) 5.3 (2.8) 0.66c
Scanner (3.0 T, 1.5 T) 18, 12 7, 6 18, 13 0.95a
APOE4, number (%) with E4 allele/number with DNA sample NA 5/11 (45) 12/29 (41) 1.00a
Neurological signs
Limb rigidity, n (%)d,e NA 13 (100) 0
Alien limb phenomena, n (%)d NA 2 (15) 0
Tremor, n (%)d NA 3 (23) 0
Myoclonus, n (%)d NA 10 (77) 14 (45) 0.10a
Asymmetrical, n (%) 8 (80) 4 (29) 0.04a
Apraxia, n (%)d N/A 13 (100) 12 (39) <0.001a
Asymmetrical, n (%) 12 (92) 2 (17) <0.001a
Limb apraxia subtest (3A) of apraxia battery for adults (ABA-2A) PCA-motor (N ¼ 4) PCA-pure (N ¼ 4)
Right upper limb scoref, mean (SD) NA 34.4 (12.3) 42.75 (10) 0.32c
Left upper limb scoref, mean (SD) NA 21.3 (13.3) 42.75 (7.3) 0.05c
Difference between left and right scores, mean (SD) NA 13 (5.9) 2 (2.3) 0.01c
p-Value for paired samples t-test comparing left and right
upper limb scores
0.02 1.00
Key: ANOVA, analysis of variance; MMSE, mini-mental state examination; NA, not applicable; PCA, posterior cortical atrophy; SD, standard deviation.
a Fisher exact test.
b One-way ANOVA.
c Two sample unpaired t-test comparing PCA-motor against PCA-pure.
d Numbers indicate the number (percentage) of patients in each group documented as manifesting the sign on clinical examination. Where indicated, the number (per-
centage) of these subjects inwhom the signwas asymmetrical that is, observed only ormore prominently on 1 side than the other, is recorded on the line below. The remaining
signs were asymmetrical in all cases.
e Limb rigidity was the feature used to deﬁne membership of the PCA-motor group and affected the left upper limb in all cases.
f Maximum score 50, with lower scores indicating more severe apraxia.
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regionsecentral, frontal, parietal, temporal, and occipital (see
Appendix). To investigate differences in laterality of cortical thick-
ness between patient groups in all 5 regions, 6 linear regressions
were performed (using Stata 12eStataCorp, 2011), 1 for each region
of interest (ROI) and 1 for all ROIs combined. Cortical thickness was
the dependent variable and group, hemisphere and their interac-
tion were the independent variables of interest. Robust standard
errors were used to account for repeated measures by patient. Age,
gender, scanner, and TIV were included as additional covariates for
adjustment. Wald tests were carried out to elucidate the main ef-
fects of group and laterality and their interaction. To compare the
size of the effect of differences between PCA-motor and PCA-pure
groups, Cohen’s d was calculated for this comparison in each of
the cortical ROIs in the right and left hemisphere.
2.8. Subcortical ROI analysis
The Multi-Atlas Propagation and Segmentation (MAPS) tech-
nique was used to investigate volumes of the subcortical structures
of interest in this study; namely the thalamus, caudate, and puta-
men. This segmentation method was previously developed for
hippocampal segmentation (Leung et al., 2010) and has been used
in brain extraction (Leung et al., 2011). In MAPS, the target T1-
weighted image is compared with all the atlases in a template li-
brary, comprising 30 MRI scans of healthy individuals which have
been manually segmented into 83 anatomic structures (Hammers
et al., 2003). Multiple best-matched atlases were used to segment
the target image, and an optimal segmentation was created by
fusing the multiple segmentations. Leave-one-out cross-validation
comparing the automated and manual segmentations of the tem-
plate library was used to determine the optimal number of best-
matched atlas (7 for putamen and thalamus and 9 for caudate)
and label-fusion algorithm (simultaneous truth and performance
level estimation) (Warﬁeld et al., 2004). We used the optimized
parameters to generate individual ROIs fromMAPS for each subject.
Linear regression analysis was used to test the effect of group, lat-
erality, and their interaction in the same way as for the cortical
thickness ROIs. Similarly, effect sizes were calculated using Cohen’s
d for the comparison between PCA-motor and PCA-pure.
3. Results
3.1. Clinical
The control and PCA groups were matched for age and gender
(see Table 1 for demographics and clinical data). The patient sub-
groups were matched for age at scan, disease duration (time be-
tween symptom onset and scan), and MMSE score. There was no
signiﬁcant difference in APOE4 allele frequency between the 2 PCA
subgroups and 2 patients in each group were E4 homozygous.
Of the 44 PCA patients, 13 (30%) met inclusion criteria for PCA-
motor and 31 (70%) for PCA-pure. In all patients with limb rigid-
ity (PCA-motor) the rigidity was asymmetrical, and in all 13 the left
arm was predominantly affected. All 13 PCA-motor patients
demonstrated apraxia on clinical examination, which was
considered by the examining neurologist to be asymmetrical (all
demonstrating worse gesture production using the left than right
hand), in 92% of them. In the PCA-pure group, apraxia was observed
in 39% and was described as asymmetrical in 17% of those with
apraxia. Therefore, although limb apraxia occurred in both groups,
it was seen signiﬁcantly more frequently (p < 0.001) and was more
frequently asymmetrical (p < 0.001) in the PCA-motor than PCA-
pure group. On the ABA-2,3A test, the mean score in the 4 PCA-
pure patients tested was 43/50 for both left and right upper limb,
which is considered indicative of mild apraxia (Dabul, 2000), with a
mean difference in scores between left and right of 2. In the 4 PCA-
motor patients tested, the mean score was 34/50 for the right
(moderate apraxia) and 21/50 (severe apraxia) for the left upper
limb, with a mean difference in scores between left and right of 13.
Although the subgroup of patients assessed with this battery was
small, the PCA-motor group demonstrated signiﬁcant asymmetry
in the severity of their apraxia between left and right upper limb
(p ¼ 0.02), which was signiﬁcantly worse than the degree of
asymmetry observed in the PCA-pure group (p ¼ 0.01).
Myoclonus was observed in both the PCA-motor (77%) and PCA-
pure (45%) group but was more frequently asymmetrical in the
PCA-motor group (p¼ 0.04). A total of 80% of those with myoclonus
in the PCA-motor group had asymmetric myclonus, which was only
or more prominently observed on the left. In the PCA-pure group,
asymmetry was observed in 29% of those with myoclonus but half
of this subgroup demonstrated worse myoclonus on the left and
half demonstrated worse on the right. In the PCA-motor group, 3
subjects (23%) had a resting tremor of the left hand and 2 subjects
(15%) had alien limb phenomena affecting the left upper limb. None
of the subjects in the PCA-pure group had a rest tremor or signs of
alien limb. No subjects were documented to have dystonia. Two of
the PCA-motor subjects had symptoms of rapid eye movement
sleep behavior disorder; both manifested myoclonus and one had
signs of alien limb. No subject reported visual hallucinations.
However, 1 PCA-motor subject had experienced extracampine
hallucinations earlier on in his illness. He described feeling a
presence on his left, with involuntary drifting of his left arm, which
began 2 years after his cognitive symptoms and resolved 3 years
later. No symptoms or signs of alien limb were evident at his
assessment, 6 years into his illness, although he did have left upper
limb rigidity, apraxia, myoclonus, and a resting tremor. The time of
onset of motor features was not clearly documented or not known
for most of the patients. However, 3/13 PCA-motor subjects had
reported difﬁculty using the left hand from the onset of their illness.
One PCA-motor and 1 PCA-pure patient underwent postmortem
pathological examination. Both had AD with Braak & Braak stage VI
neuroﬁbrillary pathology (the most severe grading and considered
diagnostic) (Braak and Braak, 1995), which involved visual cortex.
The PCA-motor case (the individual with extracampine hallucina-
tions described previously) additionally had Lewy body pathology
(LBP) in limbic and brainstem structures, and mild amyloid angi-
opathy. The PCA-pure case showed severe amyloid angiopathy but
no LBP. Another PCA-motor patient underwent a right frontal lobe
biopsy, which demonstrated AD pathology with amyloid angiop-
athy but no LBP.
Table 2
CSF results for the patients who underwent LP
Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6
Group PCA-pure PCA-pure PCA-pure PCA-pure PCA-motor PCA-motor
Total tau
(pg/mL)
931 Insufﬁcient 488 660 630 566
Ab1-42 (pg/mL) 625 105 135 343 243 205
Tau:Ab ratio 1.49 NA 3.61 1.92 2.59 2.75
Key: CSF, cerebrospinal ﬂuid; LP, lumbar puncture; NA, not applicable; PCA, posterior cortical atrophy.
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CSF total tau and Ab1-42 concentrations were analyzed for 6
other patients (2 PCA-motor, 4 PCA-Pure, see Table 2). All subjects
with complete CSF analysis had increased concentrations of total
tau supporting an underlying diagnosis of neurodegeneration. The
majority (5/6) also had low concentrations of Ab1-42 and a raised tau
to Ab1-42 ratio >1, supportive of a diagnosis of AD (Bian et al., 2008;
Blennow and Hampel, 2003). The only patient with a particularly
high Ab1-42 concentration for AD (patient 1), nonetheless had a tau/
Ab1-42 ratio >1 and was in the PCA-pure group. This individual had
a typical clinical presentation for PCA but was only very mildly
affected (MMSE 29/30) at the time of his LP. None of the patients
had a positive CSF 14-3-3 protein level.
3.2. Neuropsychology
There were no signiﬁcant differences between the PCA-motor
and PCA-pure groups on any neuropsychological test, including
assessments of visual function and naming (see Table 3). There was,
however, a trend toward worse performance in gesture production
in the PCA-motor (mean 8.6, SD 4.16) than PCA-pure group (mean
11.6, SD 4.13, p ¼ 0.08 between groups).
3.3. Voxel-based morphometry analysis
3.3.1. Gray matter
The PCA-motor group showed lower gray matter volume in the
occipital and parietal lobe regions compared with controls (peak in
right lateral occipital cortex, MNI [52, 64.5, 15]), with some
additional lateral temporal lobe involvement. On visual inspection,
differences appeared greater in the right hemisphere than the left
(Fig. 1A). A similar pattern of reduced gray matter volumes in oc-
cipital and parietal lobe regions was found in the PCA-pure group
compared with controls (peak in right lateral occipital cortex, MNI
[52, 61.5, 22.5]), however, asymmetry between hemispheres was
less pronounced. The direct comparison of PCA-motor versus PCA-
pure did not produce statistically signiﬁcant differences after cor-
recting for multiple comparisons (FWE p < 0.05). However, percent
difference maps revealed regions of lower gray matter volume on
the right in the PCA-motor group, particularly in the fronto-parietal
operculum, supramarginal gyrus, and middle part of the cingulate
gyrus, with lower left occipital volume suggested in the PCA-pure
group (Fig. 1B).
3.3.2. White matter
Effects in the white matter reﬂected those seen in the gray
matter. The PCA-motor group showed lower white matter volume
in bilateral parietal cortex compared with controls and also in the
right frontal cortex. Again, visual inspection suggested a greater
spatial extent of white matter involvement in the right hemisphere.
The PCA-pure group showed reduced white matter volume in the
parietal and temporal regions compared with controls but with less
pronounced asymmetry. The direct PCA-motor versus PCA-pure
comparison did not produce statistically signiﬁcant differences af-
ter correcting for multiple comparisons (FWE p < 0.05). However,
percent difference maps revealed regions of lower white matter
volume in the right hemisphere in the PCA-motor group, particu-
larly extending anteroposteriorly between the frontal and parietal
cortices, with lower left occipital volume suggested in the PCA-pure
group.
3.4. Cortical thickness analysis
3.4.1. Whole-brain cortical thickness results
Comparing the 2 patient groups with controls revealed reduced
cortical thickness predominantly in the occipital and parietal lobes,
including the posterior parietal lobe, precuneus, posterior cingulate
gyrus, as well as fusiform gyrus (Fig. 2A). On visual inspection,
lower cortical thickness was found bilaterally in the PCA-pure
group, whereas the PCA-motor group showed greater involve-
ment in right hemisphere regions. The direct comparison of PCA-
Table 3
Neuropsychology scores
PCA-pure
mean (SD)
PCA-motor
mean (SD)
Unpaired t test
(p-value)
Normative
mean (SD)
PCA-pure number (%)
below the 5th percentile
PCA-motor number (%)
below the 5th percentile
Interval between MRI
and psychology (months)
3.21 (4.25) 3.05 (6.04) 0.93 d d d
General function
sRMT words (/25)a 19.2 (2.83) 20.3 (2.60) 0.30 23.5 (2.10) 17 (81.0) 5 (55.6)
sRMT faces (/25)a 18.6 (5.63) 15.5 (4.71) 0.30 22.8 (1.90) 4 (19.1) 4 (44.4)
Concrete synonyms (/25)b 19.4 (5.67) 20.8 (4.63) 0.54 20.8 (3.00) 3 (14.2) 1 (11.1)
Naming from description (/20)c 13.3 (6.77) 12.4 (4.69) 0.72 18.9 (1.50) 11 (52.4) 7 (77.8)
Gesture production 11.6 (4.13) 8.56 (4.16) 0.08 d d d
Non-visual parietal
Calculation (adap. GDA/26)d 9.24 (5.20) 9.33 (5.24) 0.96 20.7 (3.10) 19 (90.5) 8 (88.9)
Spelling (Baxter/20)e 8.05 (6.71) 7.44 (7.23) 0.83 19.5 (6.49) 10 (47.6) 5 (55.6)
Visual function
Figure-ground (/20)f 15.3 (3.73) 15.0 (4.00) 0.83 19.9 (0.30) 17 (81.0) 8 (88.9)
Fragmented letters (/20)f 3.72 (4.59) 1.11 (1.62) 0.11 18.8 (1.40) 17 (81.0) 9 (100)
Object decision (/20)f 10.6 (5.31) 9.56 (4.28) 0.61 17.7 (1.90) 14 (66.7) 9 (100)
Usual views (/20)g 13.7 (7.09) 7.75 (5.74) 0.16 19.7 (0.50) 6 (28.6) 4 (44.4)
Unusual views (/20)g 4.90 (4.82) 2.25 (1.89) 0.32 17.1 (3.00) 9 (42.9) 4 (44.4)
Number location (/20)f 3.06 (3.37) 1.44 (2.01) 0.20 9.40 (1.10) 15 (71.4) 9 (100)
Dot counting (/20)f 3.95 (3.73) 3.00 (3.57) 0.53 9.90 (0.20) 17 (81.0) 8 (88.9)
Mean and standard deviation of raw scores for the PCA patient group and relevant normative data.
Key: MRI, magnetic resonance imaging; PCA, posterior cortical atrophy; sRMT, Short Recognition Memory Test.
Normative data samples are as follows:
a Warrington (1996).
b Warrington et al. (1998).
c Randlesome (unpublished data N ¼ 100).
d Crutch (unpublished data).
e Baxter and Warrington (1994).
f Warrington and James (1991).
g Warrington and James (1988).
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motor and PCA-pure did not reveal any statistically signiﬁcant
results after FWE correction. However, percent difference maps
revealed trends toward lower cortical thickness in the left occipi-
toparietal regions of the PCA-pure group, whereas the PCA-motor
group showed lower cortical thickness in the right hemisphere,
including the motor cortex (Fig. 2B).
3.4.2. Regional and lateralization cortical thickness results
Mean cortical thickness of each region in the left and right
hemisphere for each group is presented in Fig. 3. Combining all
regions and both hemispheres, pairwise comparisons revealed
lower global cortical thickness in the PCA-motor (mean 1.99 mm,
SD 0.27) and PCA-pure group (mean 2.02 mm, SD 0.30) compared
with controls (mean 2.26 mm, SD 0.25; p < 0.001 for both com-
parisons), but no evidence for an overall difference in cortical
thickness between PCA-motor and PCA-pure (p ¼ 0.73). This effect
was comparable when looking at each cortical ROI separately and is
evident in Fig. 3 (see Supplementary Table 1 for p-values and mean
differences for pairwise comparisons).
There was, however, a signiﬁcant interaction between hemi-
sphere and group in every region (p < 0.002) except frontal cortex
(p ¼ 0.514). Thus, in all regions other than frontal cortex, the dif-
ference in cortical thickness between left and right hemispheres
depended upon the patient group. Pairwise comparisons revealed
Fig. 1. Results from voxel-based morphometry analysis. (A) Differences in gray and white matter volume between controls and PCA-motor, and between controls and PCA-pure. T-
scores are shown for statistically signiﬁcant lower gray matter volume in the patient groups compared with controls (FWE corrected at p < 0.05). Images shown in neurological
convention (right on right). Cross hairs and coordinates (in MNI space) indicate t-score global maxima (this is in the right hemisphere for both comparisons). (B) Percent difference
maps for differences in gray and white matter between PCA-motor and PCA-pure. Warmer colors show regions of lower volume in PCA-motor compared with PCA-pure, whereas
cooler colors show regions for the opposite contrast. Images shown in neurological convention (right on right), coordinates are in MNI space. Abbreviations: FWE, family-wise error;
PCA, posterior cortical atrophy.
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that this was driven bymore loss in right hemisphere regions in the
PCA-motor than PCA-pure and control groups. In some regions
(parietal, occipital, and temporal) this constituted a reversal of the
asymmetry seen in controls, whereas in others (all cortical ROIs
combined and central) there was asymmetry in PCA-motor,
although there was no left-right difference in controls. There was
no evidence for a difference in the laterality of cortical thickness
between controls and the PCA-pure group in any cortical ROI.
3.5. Subcortical volumetric analysis
Pairwise comparisons for both individual and combined
subcortical ROIs (caudate, putamen, and thalamus) are shown in
Fig. 3 and Supplementary Table 1. Controls (combined mean ¼
5235 mm3, SD ¼ 1262) showed higher volumes on all metrics than
either PCA-pure patients (combinedmean¼ 4726mm3, SD¼ 1032;
p ¼ 0.001) or PCA-motor patients (combined mean ¼ 4387 mm3,
SD ¼ 1032; p ¼ 0.001). The PCA-motor group had signiﬁcantly
lower volumes than the PCA-pure group for the combined
subcortical ROIs (p ¼ 0.009), thalamus (p ¼ 0.005), and putamen
(p ¼ 0.004) but not caudate (p > 0.9).
There was a signiﬁcant interaction between hemisphere and
group in all regions combined (p < 0.001), thalamus (p < 0.001),
and putamen (p < 0.001) but not caudate (p ¼ 0.075). As with the
cortical regions of interest, pairwise comparisons revealed that this
interaction was driven by lower volumes in right hemisphere re-
gions in the PCA-motor group than PCA-pure and control groups. In
all subcortical regions combined and the thalamus separately,
controls and PCA-pure showed asymmetry with greater volume in
the right hemisphere, although this asymmetry was absent in the
Fig. 2. Results from cortical thickness analysis. (A) Differences in cortical thickness between controls and PCA-motor, and between controls and PCA-pure. The color scale represents
FWE corrected p-values (p < 0.05), with warmer colors representing regions with lower cortical thickness in the patient groups compared with controls, and cooler colors showing
the opposite contrast (which yielded no statistically signiﬁcant results). (B) Difference in cortical thickness between PCA-pure and PCA-motor. The color scale represents percent
differences in cortical thickness with warmer colors showing regions where PCA-motor has lower cortical thickness compared with PCA-pure, whereas cooler colors represent areas
for the opposite contrast. Abbreviations: FWE, family-wise error; PCA, posterior cortical atrophy.
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PCA-motor group. The magnitude of thalamic asymmetry did not
differ between controls and PCA-pure but both groups were
signiﬁcantly more asymmetrical than PCA-motor (p< 0.001). In the
putamen, evidence for a left-right difference in volume was absent
in PCA-motor, weak in controls and strong in PCA-pure, with con-
trol and PCA-pure groups both showing greater volumes on the
right. Evidence for a difference in the magnitude of putaminal
asymmetry was absent for controls versus PCA-pure, weak for
controls versus PCA-motor (p ¼ 0.057) and strong for PCA-motor
versus PCA-pure (p ¼ 0.008).
3.6. Effect size analysis
Large effect sizes for the difference between PCA-motor and
PCA-pure were found in the right thalamus and right putamen.
Medium effect sizes were found in the right parietal, right temporal,
and right central ROIs. Small effect sizes were found in right frontal,
left parietal, left central and bilateral occipital regions, left puta-
men, and left thalamus (Supplementary Table 2). These effect sizes
represent greater atrophy in the PCA-motor group than the PCA-
pure group except for the left parietal and left occipital regions
where atrophy was greater in the PCA-pure group.
4. Discussion
This study demonstrates an important overlap syndrome of PCA
and CBS and reveals signiﬁcant differences in the clinical and
neuroimaging proﬁles of PCA patients with and without the core
clinical features of CBS. All patients participating in the study met
the originally proposed clinical criteria for PCA, of which 13 (30%)
also showed prominent asymmetrical limb rigidity. Limb apraxia
was evident on clinical examination in both the PCA-motor and
PCA-pure groups but was seenmore frequently, andwasmore often
observed to be asymmetrical, in the PCA-motor group. This differ-
ence in asymmetry of apraxia between the groups was conﬁrmed in
the subgroup who underwent standardized assessment with the
ABA-2,3A. Myoclonus was also seen in both groups but was more
often asymmetrical in the PCA-motor group. Rest tremor and alien
limb phenomena were only observed in the PCA-motor group.
Other than a trend toward greater impairment on gesture pro-
duction tests of praxis, no signiﬁcant difference in neuropsycho-
logical measures was observed between the PCA-motor and
PCA-pure groups. Clearly, the presence of prominent limb rigidity
may impair an individual’s ability to produce hand gestures so it is
perhaps not surprising that more prominent and asymmetrical
apraxia was observed in the PCA-motor group, where rigidity was
used to deﬁne group membership. Teasing out the relative contri-
bution of different motor signs can be difﬁcult; myoclonus, tremor,
and alien limb phenomena may also impact upon gesture produc-
tion. The different motor signs should perhaps, therefore, be
considered less as independent observations and more as a
constellation of features that contribute to difﬁculty using the
affected limb in a signiﬁcant proportion of PCA patients in our
cohort.
Neuroimaging analyses revealed overlapping but distinct pat-
terns of tissue loss in the PCA-motor and PCA-pure groups. Both
gray and white matter volume and cortical thickness techniques
revealed more asymmetry in the PCA-motor than the PCA-pure
group compared with controls, with more pronounced atrophy
and reductions in thickness in the right hemisphere in the PCA-
motor group. The regions found to show the greatest difference in
VBM between these groups were the frontoparietal operculum,
supramarginal gyrus, and middle part of the cingulate gyrus, all
anterior to the maxima identiﬁed in the patient-control compari-
sons. These differences could not be attributed to age or disease
duration and suggest a greater spatial extent of atrophy in the PCA-
motor than PCA-pure group. The cortical thickness analysis showed
a similar trend toward right-sided atrophy, and particularly
emphasized the involvement of the perirolandic sensory and motor
cortices (bilaterally but more on the right) in the PCA-motor group.
Subcortical region of interest volumetric analysis revealed lower
volumes of putamen and thalamus in the PCA-motor group
compared with the PCA-pure group and healthy controls, an effect
that was the strongest in the right hemisphere.
Asymmetry, with greater atrophy in the right hemisphere, was a
prominent and distinctive feature of the PCA-motor group and may
underlie the left upper limb motor features that were observed in
these patients. The results are consistent with the hypothesis that
CBS signs in PCA reﬂect atrophy of contralateral sensorimotor
cortices. The data extend the hypothesis by demonstrating that
such signs are also associated with greater tissue loss in subcortical
structures, namely the putamen and thalamus. The thalamus and
putamen have been found to undergo signiﬁcant atrophy in AD (De
Jong et al., 2008), however, their differential involvement in atyp-
ical AD phenotypes has not, to our knowledge, been systematically
evaluated. Thalamic and basal ganglia volume loss on MRI has also
been identiﬁed in CBS, however, does not appear to differentiate
between CBS cases with underlying CBD or AD pathology (Josephs
Fig. 3. Mean cortical thickness and subcortical volume for each patient group in each region of interest. Error bars indicate standard error.
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et al., 2010). In our study, the control and PCA-pure groups both
showed greater volumes in the right thalamus and putamen. This
normal asymmetry was lost in the PCA-motor group, implying that
these structures had undergone a greater degree of atrophy in the
right hemisphere. It seems likely that the prominent motor features
in the PCA-motor group reﬂect dysfunction of a whole network of
areas involved in the planning, coordination, and execution of
movement. This includes the primary motor and somatosensory
cortices, premotor and supplementary motor areas, and the pos-
terior parietal and deep subcortical structures with which they
connect.
It was striking that the asymmetric motor features affected the
left side in all subjects in the PCA-motor group. Interestingly, the
right side was involved more than the left in a series of CBS patients
presenting with language, behavioral, or motor symptoms, with left
hemispheric atrophy a frequent ﬁnding (Kertesz et al., 2000). Thus,
it may be that our ﬁnding of motor features affecting the left side
only reﬂects sampling bias in terms of the patients that are referred
and labeled as having PCA. Patients with predominantly right
hemisphere deﬁcits affecting their vision may be more likely to
present to a cognitive neurologist and be diagnosed with PCA than
those with predominantly left hemisphere deﬁcits such as pro-
gressive apraxia or dysgraphia. The latter type of patient is perhaps
more likely to be referred to a movement disorders specialist and, if
motor features are present (which would likely show a right limb
predominance), be diagnosed with CBS. Supporting this hypothesis,
a predominantly right-sided pattern of cortical atrophy has been
reported in prior imaging studies of PCA (Lehmann et al., 2011a;
Whitwell et al., 2007), and it has been proposed that this may be
because of the relatively high proportion of patients with pre-
dominantly right hemisphere deﬁcits in most PCA cohorts
(Lehmann et al., 2011a). Our data showed no difference in the
symmetry of cortical thickness between controls and the PCA-pure
group in any cortical ROI. This perhaps suggests that asymmetry in
PCA group studies may also be driven by the subset of subjects with
additional features of CBS. Despite the difference in asymmetry
between the PCA-motor and PCA-pure groups there was consid-
erable overlap in their overall atrophy and cortical thickness pat-
terns, with both groups showing the greatest differences from
controls in occipital and parietal regions. It is therefore not sur-
prising that apraxia and myoclonus were observed in both groups,
as parietal lobe lesions may cause both of these clinical signs (Fahn
et al., 2011).
There is signiﬁcant pathological overlap in the etiology of PCA
and CBS, with both potentially being caused by underlying AD, CBD,
DLB, or CJD. Some clinicopathological studies investigating CBS
patients with underlying AD or CBD have indicated that behavioral
and/or frontal symptoms such as early personality change predict
CBD pathology whereas impairment of visuospatial skills and
memory, young age at onset andmyoclonus are associated with AD.
The presence of asymmetrical extrapyramidal signs, apraxia, or
alien limb phenomena has not generally appeared to differentiate
between CBS-CBD and CBS-AD (Hassan et al., 2011; Hu et al., 2009;
Lee et al., 2011; Shelley et al., 2009). In PCA, which is characterized
by prominent visuospatial impairment and in which young age at
onset, myoclonus, and preservation of personality are commonly
seen, additional features of CBS may still therefore associate with
AD pathology. Contrary to the traditional view, it is in fact CBD that
often appears to present without motor symptoms (with a frontal
cognitive and/or behavioral syndrome) (Lee et al., 2011) or with
motor features that are symmetrical (Hassan et al., 2010). In our
cohort, AD pathology was conﬁrmed in the 2 PCA-motor patients
who underwent postmortem examination and was suggested by an
AD-like CSF proﬁle in the 2 other PCA-motor patients who under-
went LP. The ﬁnding of additional LBP in the PCA-motor case is
intriguing, particularly given this subject’s history of extracampine
hallucinations, and raises the possibility that concomitant LBP may
inﬂuence the phenotype of AD. Additional LBP was found in 2 of the
5 pathologically conﬁrmed CBS-AD patients reported by Josephs
et al. (2010), one of whom developed visual hallucinations 6 years
into her illness. Two of the 6 patients in the Tang-Wai PCA series
with Parkinsonism had AD pathology with concomitant LBP; both
subjects also had visual hallucinations, although neither the hal-
lucinations nor Parkinsonismwere present initially (Tang-Wai et al.,
2004). Another 2 of the subjects in this series had CBD at post-
mortem, having shown signs of asymmetrical Parkinsonism and
apraxia during life, demonstrating that PCAwithmotor features can
be associated with non-AD pathology too. This has also been sug-
gested by a previous CSF study, in which 1 of the 3 PCA subjects
with asymmetric motor features had an AD-like CSF proﬁle but CSF
was normal for the other 2 (Seguin et al., 2011). Larger clinico-
pathological series will be needed to investigate whether AD with
LBP does associate with motor features in PCA and to ascertain how
frequently the phenotype is caused by CBD.
There is some evidence that imaging signatures may help to
differentiate CBS subjects with pathologically conﬁrmed AD (CBS-
AD) from those with underlying CBD pathology. Greater atrophy of
temporoparietal cortex and precuneus has been observed in pa-
tients with CBS-AD whereas CBS-CBD patients demonstrated more
frontal atrophy (Josephs et al., 2010; Whitwell et al., 2010). CBS
patients with an AD-like CSF proﬁle have also shown greater
hypoperfusion in precuneus and posterior cingulate cortex on sin-
gle photon emission computed tomography scans than CBS patients
with non-AD like CSF (Borroni et al., 2011). In our study, the fact that
indirect (vs. controls) and direct comparisons between the PCA-
motor and PCA-pure groups revealed predominant impairment of
parietal and occipital but notmore frontal regions supports the idea
that the group differences reﬂect heterogeneity within the PCA
syndrome, of which AD remains the commonest underlying cause,
rather than suggesting that CBD pathology accounts for the PCA-
motor phenotype.
The pathological overlap in the etiology of PCA and CBS em-
phasizes the need for improved clarity as to the clinical overlap
between the 2 syndromes. Considering current clinical criteria for
PCA (Mendez et al., 2002; Tang-Wai et al., 2004) and CBS (Boeve
et al., 2003; Lang et al., 1994; Mathew et al., 2012), considerable
overlap is evident meaning that some patients may fulﬁll criteria
for both syndromes, as has been illustrated by a recent case report
(Giorelli et al., 2014). This is particularly apparent in more recent
CBS criteria, which have emphasized early cognitive change in ex-
ecutive function, language, memory, and/or visuospatial process-
ing. For example, themodiﬁed Bak and Hodges (Cambridge) criteria
for CBS could be met by PCA patients with insidious onset and no
sustained levodopa response (mandatory criteria), limb apraxia and
language impairment (major features) and a combination of at least
2 of alien limb phenomenon, cortical sensory loss, dyscalculia, and
visual dysfunction (Mathew et al., 2012). Although typically
considered a progressive visual syndrome, anomia, and phonolog-
ical processing deﬁcits are common early features in PCA (Benson
et al., 1988; Crutch et al., 2013a; McMonagle et al., 2006).
Conversely, patients fulﬁlling CBS criteria may also fulﬁll PCA
criteria, which either have no exclusion criteria (Mendez et al.,
2002) or exclude only early Parkinsonism (Tang-Wai et al., 2004).
Thus, individuals diagnosed with CBS who have visual complaints
and signs such asmyoclonus, limb apraxia, alien limb phenomenon,
and cortical sensory loss would still meet current criteria for PCA
(Rajagopal et al., 2012).
Clarifying the relationship between PCA and CBS would have a
number of implications for diagnosis, management, and research.
First, although the presence of linguistic and executive dysfunction
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in CBS patients may not distinguish underlying pathologies (Lee
et al., 2011), the presence of cortical visual dysfunction, and other
posterior cortical deﬁcits may weight the diagnostic probabilities
toward AD. Consistent with this view, Rabinovici and Miller (2012)
have speculated that some features within the modiﬁed Cambridge
criteria for CBS such as visuospatial dysfunction and myoclonus
may be predictive of AD. There is some support for this idea from a
recent study of CBS patients with amyloid imaging using Pittsburgh
compound B, which demonstrated greater visuospatial deﬁcits in
those with evidence of AD (amyloid) pathology than in those who
were Pittsburgh compound B-negative (Burrell et al., 2013). Second,
the current evidence of CBS-like motor features in a substantial
proportion of PCA patients argues against any tendency to withhold
currently available AD therapeutic treatments such as acetylcho-
linesterase inhibitors to PCA patients with these signs. Conversely,
CBS patients presenting to movement disorders specialists should
be examined closely for posterior cortical deﬁcits and, if the
phenotype suggests AD, offered appropriate treatment. The vast
majority of patients with PCA have underlying AD (de Souza et al.,
2011; Renner et al., 2004), and there is no evidence to date that the
co-occurrence of CBS-like signs makes that diagnosis any less likely.
In fact, the pathological and CSF data in this study, although limited,
were consistent with an underlying diagnosis of AD in all the PCA-
motor patients for whom this information was available. Third,
although a syndromic classiﬁcation could be adequate for some
types of research study (e.g., brain-behavior correlations or
behavioral interventions), other investigations will need direct
consideration of probable underlying pathology (e.g., clinical trials
of protein-speciﬁc therapies). Finally, the identiﬁcation of CBS-like
signs in patients who fulﬁll criteria for PCA has a bearing upon
how inclusively or exclusively PCA should be deﬁned in any future
consensus criteria; for instance, should the term PCA only be
applied to patients with predominant visual dysfunction (as spec-
iﬁed by existing clinical criteria e.g., Mendez et al., 2002; Tang-Wai
et al., 2004) or should the syndrome encompass patients with
progressive deterioration in other cognitive domains such as
calculation, spelling, and praxis (Aharon-Peretz et al., 1999; De
Renzi, 1986; Green et al., 1995; Seguin et al., 2011; Snowden et al.,
2007). Inclusivity is intuitively appealing given that the term PCA
refers to the locus of focal atrophy rather than a particular set of
clinical features. However, it might come at the cost of reduced
speciﬁcity (in both syndromic and pathological terms) given re-
ports of posterior cortical presentations with non-AD, non-CBD
etiologies, for example CBS caused by a progranulin mutation pre-
senting as progressive apraxic agraphia (Passov et al., 2011).
To our knowledge, this is the ﬁrst study to compare directly the
clinical and neuroimaging features of PCA patients with and
without the core motor features of CBS. One limitation of the study
is the relatively small number of subjects, which may explain the
ﬁnding that although volumetric and cortical thickness asymme-
tries were evident at the level of control-patient comparisons and
between-patient group percentage effect maps, direct comparisons
between the 2 groups did not survive correction for multiple
comparisons. However, this is a common problem when studying
relatively rare degenerative conditions (Whitwell et al., 2007) and
may be rectiﬁed with larger samples (Lehmann et al., 2011a). The
MRI scans used in this study were acquired from scanners of
different ﬁeld strengths, which have the potential to introduce bias.
However, the groups were well matched in terms of the proportion
of scans acquired on each scanner, and scanner was included as a
covariate in the imaging analyses to avoid an inﬂuence upon the
results. Another limitation of the study was that detailed neuro-
psychological data and a standardized clinical assessment of limb
apraxia were only available in a subset of patients. Although the
neuropsychological results revealed a trend toward lower
performance in gesture production in the PCA-motor group, further
study should investigate the cognitive correlates of PCA with fea-
tures of CBS inmore detail. Despite only having been performed in a
small subgroup of patients, the apraxia battery demonstrated
signiﬁcantly more asymmetry and a greater severity of left upper
limb apraxia in the PCA-motor compared with PCA-pure group.
This highlights the value of applying standardized clinical assess-
ment tools to investigate neurological signs, such as the ABA-2 to
evaluate apraxia, and the importance of assessing the left and right
side separately in a condition like PCA. The retrospective nature of
this study, with reliance on the recording of neurological signs by a
number of different clinicians, were inevitable limitations which
we attempted to overcome by only including patients with a clearly
documented full neurological examination. Larger cohorts of pa-
tients, with clinicopathological correlation, will ultimately be
required to further investigate the insights raised by this study.
Multicenter collaboration may be needed to achieve this, particu-
larly if the potential genetic factors underlying phenotypic het-
erogeneity in PCA are to be evaluated. The recent establishment of
an international PCA Working Party represents a positive step in
taking such collaboration forward (Crutch et al., 2013b), and in
opening a dialog on the challenge of deﬁning the syndrome of PCA,
with appreciation of the motor as well as cognitive features that it
may entail.
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Appendix
Supplementary Table 1
Division of 34 Desikan regions into 5 groups
Region of interest Desikan region
Central Paracentral
Central Postcentral
Central Precentral
Central Posterior cingulatea
Frontal Caudal anterior cingulate
Frontal Caudal middle frontal
Frontal Frontal pole
Frontal Lateral orbitofrontal
Frontal Medial orbitofrontal
Frontal Pars opercularis
Frontal Pars orbitalis
Frontal Pars triangularis
Frontal Rostral anterior cingulate
Frontal Rostral middle frontal
Frontal Superior frontal
Occipital Lateral occipital
Occipital Lingual
Occipital Pericalcarine
Occipital Cuneus
Parietal Inferior parietal
Parietal Isthmus cingulate
Parietal Precuneus
Parietal Superior parietal
Parietal Supramarginal
Temporal Bankssts
Temporal Entorhinal
Temporal Fusiform
Temporal Inferior temporal
Temporal Insula
Temporal Middle temporal
Temporal Parahippocampal
Temporal Superior temporal
Temporal Temporal pole
Temporal Transverse temporal
a The region labeled posterior cingulate in the Desikan atlas (Desikan
et al., 2006) is directly inferior to the paracentral lobule, rather than the
posterior-most end of the cingulate, and was therefore placed in the central
region of interest.
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